Synapsoft logo
AI Insights from Disclosures
Searching...
NeoImmuneTech, Inc. 950220
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
NeoImmuneTech, Inc. is a biotechnology company engaged in the research and development of T cell-based immunotherapies. The company is researching and developing NT-I7, a T cell amplifier, as well as its antibody platform technology, the Heterodimer hybrid Fc platform, and NT2020 (T cell activator), NT3020 (T cell Engager), NT4010 (Advanced CAR-T), and NT5010 (TME modifier).
Representative Director Kim Taegyeong
Founded January 29, 2014
Corporation Type KOSDAQ
Industry Classification Interdisciplinary convergence research and experimental development on natural sciences and engineering
Corporate number -
Business number 474-52-
Phone Number +1-240-801-9068
Fax Number 0317398303
Company Address 2400 Research Boulevard, Suite 250, Rockville, MD 20850
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant